emactuzumab

Ukraine

Drugs containing this active substance

HEMLIBRA

The drug is intended for routine prophylaxis to prevent or reduce the frequency of bleeding in adults and children (from birth) with hemophilia A.

Form: solution for injection

Active substance	Dosage
emactuzumab	150 mg/ml

Manufacturer: Chugai Pharma Manufacturing Co, Ltd (manufacturing of unpackaged products, primary packaging, quality control testing; quality control testing)